Literature DB >> 38914

Cardiac atrial myosin adenosine triphosphatase of animals and humans: distinctive enzymatic properties compared with cardiac ventricular myosin.

Y Yazaki, S Ueda, R Nagai, K Shimada.   

Abstract

Cardiac myosin obtained from atria had a higher Ca2+-activated ATPase activity than did cardiac myosin from ventricles in various species of animals and in humans. The increased specific activity of Ca2+-activated adenosine triphosphatase (ATPase) of atrial myosin appeared to correlate with the level of the activity of ventricular myosin ATPase in the animal, since the same order in ATPase activity, as observed in ventricular myosins from various animals, was noted in atrial myosins. The enzymatic properties of atrial myosin also were characterized by no activation by N-ethylmaleimide, low activating energy, and a lower rate of inactivation at alkaline pH compared with the same properties of ventricular myosin. These findings suggest a difference in the myosin molecule at or near the active site, involving some sulfhydryl groups, between the two types of cardiac myosin. The Mg2+-activated ATPase activity, both in the presence and absence of actin (which is thought to be closely related to the basic contraction mechanism), also was enhanced in atrial myosin. Thus, the ATPase activities of atrial and ventricular myosins were different with special reference to the reaction pathway involving calcium and magnesium ions and appear to account for the difference in the velocity of contraction between the atria and the ventricles.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 38914     DOI: 10.1161/01.res.45.4.522

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  17 in total

1.  Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium.

Authors:  M Kurabayashi; H Tsuchimochi; I Komuro; F Takaku; Y Yazaki
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

2.  Atrial and ventricular myosin ATPase--divergence with increasing animal species size.

Authors:  I Syrový
Journal:  Pflugers Arch       Date:  1985-05       Impact factor: 3.657

3.  Heterogeneity of beta-type myosin isozymes in the human heart and regulational mechanisms in their expression. Immunohistochemical study using monoclonal antibodies.

Authors:  H Tsuchimochi; M Kuro-o; H Koyama; M Kurabayashi; M Sugi; F Takaku; S Furuta; Y Yazaki
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

4.  Distribution of cardiac myosin isozymes in human conduction system. Immunohistochemical study using monoclonal antibodies.

Authors:  M Kuro-o; H Tsuchimochi; S Ueda; F Takaku; Y Yazaki
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

5.  Relaxation in atrial and ventricular myocardium: activation decay and different load sensitivity.

Authors:  C Poggesi; C Reggiani; R Bottinelli; L Ricciardi; R Minelli
Journal:  Basic Res Cardiol       Date:  1983 May-Jun       Impact factor: 17.165

Review 6.  Some aspects of cardiac heterogeneity.

Authors:  H G Zimmer
Journal:  Basic Res Cardiol       Date:  1994 Mar-Apr       Impact factor: 17.165

Review 7.  Contractile proteins in muscle disease.

Authors:  P Cummins
Journal:  J Muscle Res Cell Motil       Date:  1983-02       Impact factor: 2.698

8.  Myocardial cell heterogeneity in the human heart with respect to myosin ATPase activity.

Authors:  L E Thornell; S Forsgren
Journal:  Histochem J       Date:  1982-05

9.  Isozymic changes in myosin of human atrial myocardium induced by overload. Immunohistochemical study using monoclonal antibodies.

Authors:  H Tsuchimochi; M Sugi; M Kuro-o; S Ueda; F Takaku; S Furuta; T Shirai; Y Yazaki
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

10.  Ultrastructural alterations in the atrial myocardium of pigs with acute monensin toxicosis.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.